Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

30.82 +0.20 (+0.65%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Market Commentary: “Volumes Are The Name Of The Game…”
Short, intermediate, and long term outlook on the market. Plus, a deep dive into our thesis on Cooper Standard 
Via Talk Markets
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Barclays Maintains Overweight Rating for Baxter Intl: Here's What You Need To Know
Via Benzinga
Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit
Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, Therapies, Kidney Care, and Pharmaceuticals segments. 
Via Benzinga
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
From Baxter International Inc.
Via Business Wire
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Baxter International Inc. (NYSE: BAX) Highlighted for Surprising Price Action
Via Investor Brand Network
Earnings Outlook For Baxter Intl
Via Benzinga
Top Picks 2024: Baxter International
Baxter International (BAX) has four divisions: Medical Products & Therapies, Healthcare Systems & Technologies, Pharmaceuticals, and Kidney Care. The stock aggressively sold off ~65% 
Via Talk Markets
Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records. 
Via Talk Markets
3 Of Our Favorite Dividend Stocks For The New Year
The S&P 500 Index appears to be wrapping up a strong year, registering a year-to-date total return of 22.2%. The good news is that there are still undervalued stocks with strong dividends to choose... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals
From Baxter International Inc.
Via Business Wire
Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Baxter International Inc.
Via Business Wire
Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Baxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North America
From Baxter International Inc.
Via Business Wire
Morgan Stanley Maintains Equal-Weight Rating for Baxter Intl: Here's What You Need To Know
Via Benzinga
The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Most Active Equity Options For Midday - Monday, Nov. 13
Here are the most active equity options for midday. 
Via Talk Markets
Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure
From Baxter International Inc.
Via Business Wire
Why Is Dialysis Device And Kidney Care Provider Baxter Stock Trading Higher Today?
Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.71 billion, which beat the consensus of $3.69 billion, up 3% Y/Y on a reported basis and  
Via Benzinga
Baxter Reports Third-Quarter 2023 Results
From Baxter International Inc.
Via Business Wire
NYSE:BAX Long Term Investor Alert: Investigation of Potential Wrongdoing at Baxter International Inc.
San Diego, CA -- (SBWIRE) -- 10/23/2023 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Baxter International Inc.. 
Via SBWire
The Value Deepens for Medtech Stocks: Reversal Imminent
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows. 
Via MarketBeat
Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope
From Baxter International Inc.
Via Business Wire
Most Active Equity Options For Midday - Wednesday, Oct. 12
Here are the most active equity options for midday. 
Via Talk Markets
BAXTER ALERT: Bragar Eagel & Squire, P.C. is Investigating Baxter International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Why Investors Punished Baxter International Stock Today
The latest data from the lab could spell trouble for the company. 
Via The Motley Fool
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.